Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pool Advista Finance Tbk. (POLA) vs Organon Pharma Indonesia Tbk. (SCPI)

Pool Advista Finance Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pool Advista Finance Tbk. dan Organon Pharma Indonesia Tbk.: Pool Advista Finance Tbk. diperdagangkan di Rp76 (kapitalisasi pasar 237,93 M, volume 24 jam 216,92 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pool Advista Finance Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

POLASCPI
Kapitalisasi Pasar
237,93 M104,4 M
Volume
216,92 jt
Lot
2,17 jt
Perputaran
17,52 M
Harga Rata-rata
80,77
Nilai Transaksi
17,52 M
Harga Ekuilibrium Indikatif
76
Volume Ekuilibrium Indikatif
10,81 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

POLA
Lihat detail
SCPI
Lihat detail

Tentang Pool Advista Finance Tbk.

PT Pool Advista Finance Tbk (the Company), formerly PT Indojasa Pratama Finance was established based on Notarial Deed of Paulus Widodo Sugeng Haryono, S.H., No. 65 dated May 21, 2001. In 2002, Indojasa Finance obtained a business license as a Financing Company, and in 2003, Indojasa Finance entered the capital market by issuing bonds.

Selengkapnya di halaman POLA

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI